Applied Therapeutics Inc (NASDAQ: APLT) is 195.52% higher on its value in year-to-date trading and has touched a low of $1.79 and a high of $10.62 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The APLT stock was last observed hovering at around $10.24 in the last trading session, with the day’s loss setting it -0.34%.
Currently trading at $9.90, the stock is 8.04% and 23.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.89 million and changing -3.32% at the moment leaves the stock 69.05% off its SMA200. APLT registered 387.68% gain for a year compared to 6-month gain of 113.36%. The firm has a 50-day simple moving average (SMA 50) of $7.9176 and a 200-day simple moving average (SMA200) of $5.82165.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.36% loss in the last 1 month and extending the period to 3 months gives it a 67.23%, and is 2.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.46% over the week and 6.46% over the month.
Applied Therapeutics Inc (APLT) has around 25 employees, a market worth around $1.15B and $10.66M in sales. Profit margin for the company is -905.38%. Distance from 52-week low is 453.07% and -6.81% from its 52-week high. The company has generated returns on investments over the last 12 months (-1270.08%).
with sales reaching $830k over the same period.The EPS is expected to grow by 12.49% this year, but quarterly earnings will post -82.00% year-over-year. Quarterly sales are estimated to shrink -224.40% in year-over-year returns.
Applied Therapeutics Inc (APLT) Top Institutional Holders
140.0 institutions hold shares in Applied Therapeutics Inc (APLT), with institutional investors hold 96.63% of the company’s shares. The shares outstanding are 116.36M, and float is at 87.13M with Short Float at 13.93%. Institutions hold 91.57% of the Float.
The top institutional shareholder in the company is FRANKLIN RESOURCES INC with over 10.21 million shares valued at $47.69 million. The investor’s holdings represent 8.1496% of the APLT Shares outstanding. As of 2024-06-30, the second largest holder is VR ADVISER, LLC with 9.54 million shares valued at $44.57 million to account for 7.6149 of the shares outstanding. The other top investors are PERCEPTIVE ADVISORS LLC which holds 8.01 million shares representing 6.3877% and valued at over $37.38 million, while JANUS HENDERSON GROUP PLC holds 6.103 of the shares totaling 7.65 million with a market value of $35.49 million.
Applied Therapeutics Inc (APLT) Insider Activity
The most recent transaction is an insider sale by Funtleyder Leslie D., the company’s Chief Financial Officer. SEC filings show that Funtleyder Leslie D. sold 13,530 shares of the company’s common stock on Aug 22 ’24 at a price of $5.83 per share for a total of $78880.0. Following the sale, the insider now owns 0.28 million shares.
Applied Therapeutics Inc disclosed in a document filed with the SEC on Aug 22 ’24 that Perfetti Riccardo (Chief Medical Officer) sold a total of 22,681 shares of the company’s common stock. The trade occurred on Aug 22 ’24 and was made at $5.83 per share for $0.13 million. Following the transaction, the insider now directly holds 0.99 million shares of the APLT stock.
Still, SEC filings show that on Aug 13 ’24, Shendelman Shoshana (President and CEO) disposed off 357,423 shares at an average price of $6.18 for $2.21 million. The insider now directly holds 4,810,430 shares of Applied Therapeutics Inc (APLT).
